Original filing text · Part I

Item 3 — Quantitative and Qualitative Disclosures About Market Risk

Prestige Consumer Healthcare Inc. · 10-Q · Q1 FY2027 · Period ended Jun 30, 2026

This is the extracted source text from the SEC filing. Formatting may differ from the original document.

For quantitative and qualitative disclosures about market risk, see Item 7a. "Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for the year ended March 31, 2026. Our exposures to market risk have not changed materially since March 31, 2026.